関連する実験動画
Updated: May 13, 2026

12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 10, 2011
シムバスタチンは,Staphylococcus aureusのアルファ毒素の炎症特性を抑制する
Diethard Pruefer1, Joachim Makowski, Martin Schnell
1Department of Cardiothoracic and Vascular, Johannes Gutenberg-University, Mainz, Germany.
Circulation
|October 16, 2002
まとめ
シムバスタチンの前処置は,血液血管におけるアルファ毒素誘発の白血球相互作用を著しく減少させます. この発見は,スタチンが感染症に対する新しい治療戦略である可能性があることを示唆しています.
科学分野:
- 血管生物学 血管生物学
- 免疫学 免疫学とは
- 薬理学 薬理学とは
背景:
- HMG-CoA還元酵素阻害剤であるシムバスタチンは,白血球の活動を抑制することで,コレステロールを低下させ,血管疾患に有益です.
- スタチンは白血球の回転,粘着,転移を抑制し,血管炎症において決定的な役割を果たします.
研究 の 目的:
- シムバスタチンの前処置が,エクソトキセミア中のアルファ毒素誘発の白血球-内皮細胞相互作用を緩和できるかどうかを調査する.
主な方法:
- ネズミの中腔微循環における腸内顕微鏡検査で,白血球と内皮細胞の相互作用を観察する.
- シムバスタチンは,S. aureusアルファ毒素によるエクソトキシエミアの誘発の18時間前に投与された.
- 白血球の転移,粘着,転移,P-セレクチン発現の分析.
主要な成果:
- シムバスタチンの前治療は,エクソトキシン誘発の白血球の転移 (71+/-10〜14+/-4.7細胞/分) とアデレンス (14+/-3.5〜0.4+/-0.2細胞) を著しく抑制しました.
- また,白血球の伝播もシンバスタチンにより有意に減少しました (10.5+/-1.2から4.2+/-0.9細胞).
- シムバスタチンは,P-セレクチン発現を50%低下させ,内皮中の酸化窒素合成酵素III発現を強めた.
結論:
- シムバスタチンは,エクソトキシンによって誘発された白血球-内皮細胞の相互作用を効果的に妨害します.
- これらの発見は,スタチン療法が,エキゾトキセミアを含む感染症に対する新しい治療アプローチを表す可能性があることを示唆しています.
関連する概念動画
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Bacterial Toxins
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

